First read for a new ticker takes about 20–30 seconds while we build the analysis from the latest fundamentals, estimates, and intelligence. It's saved after this, so future visits are instant.
Thesis: Phunware: the story is balanced — Major enterprise contract announcements or renewals - single large deals can represent 10-20% of annual revenue given…
★ Analysts see FY2026 revenue reaching $4M — +37.2% growth in a single year.
What Moves the Stock
1Major enterprise contract announcements or renewals - single large deals can represent 10-20% of annual revenue given small base
2Liquidity events and dilution risk - equity raises, warrant exercises, or going concern warnings trigger sharp moves given precarious cash position
3Blockchain/crypto narrative momentum - stock exhibited meme-stock characteristics in 2021, sensitive to Web3 hype cycles and retail trader interest
4Customer churn or vertical market penetration - loss of key healthcare/hospitality clients or expansion into new verticals materially impacts growth trajectory
5Platform subscriptions and licenses (~50-60% estimate): recurring SaaS fees for MaaS platform access, SDK licenses, and cloud infrastructure
6Application services (~30-40% estimate): custom mobile app development, integration services, and professional consulting for enterprise clients
7Data/advertising services (~10-15% estimate): location-based advertising, audience analytics, and programmatic ad monetization through mobile apps
Watch on earnings: Monthly cash burn rate and ending cash balance - determines survival runway, Quarterly revenue trajectory - stabilization vs. continued decline indicates business viability, Customer count and average contract value - leading indicators of revenue sustainability.
One Sentence Summary:
Phunware: the story is balanced — major enterprise contract announcements or renewals - single large deals can represent 10-20% of annual revenue given small base.
Auto-composed from Stock Alarm intelligence, financial statements, and analyst estimates. Not investment advice.